Acaster Lloyd Consulting researchers, Sarah Acaster and Katy Gallop, have been partnering with Aimmune Therapeutics psychologists, Audrey Dunn-Gavin and Rebecca Knibb, healthcare providers and patient advocacy groups across Europe for the past four years exploring the impact of Peanut Allergy on the health-related quality of life.
We are very pleased that a large-scale (> 100 interviews) pan-European qualitative study of the impact of peanut allergy on adults, teenagers, children and parent/caregivers across eight European countries was selected for a mention in the Editorial of Clinical and Experimental Allergy this month, by editor-in-chief Graham Roberts, along with a replication of the conceptual model. Furthermore, the cover of the journal was developed to reflect the content of the qualitative findings.
To compliment this qualitative work, two burden of illness surveys reporting child and caregiver health-related quality of life in the UK have also recently been published quantifying the impacts highlighted in the qualitative work with validated patient and observer-reported measures.
It’s great to see qualitative work in this field getting such recognition, and this high unmet need being recognised and addressed.